7 Literaturverzeichnis
[1] Böcker W, Denk H, Heitz P, Moch H: Pathologie. Urban und Fischer Verlag, 4.
Auflage, 2008
[2] Herold, G: Innere Medizin. Herold Verlag, 2007
[3] Siegenthaler W, Blum HE: Klinische Pathophysiologie. Georg Thieme Verlag Stuttgart, New York 9. Auflage, 2006
[4] http://www.framinghamheartstudy.org/about/history.html
[5] Bühling, K J, Lepenies, J, Witt, K: Intensivkurs Allgemeine und Spezielle Pathologie. Urban & Fischer Verlag, 4. Auflage, 2008
[6] Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speitzer FE, Hennekens CH:
Menopause and the risk of coronary heart disease in women. N Engl J Med 1987;316:1105-1110
[7] Hayashi S, Yamada K, Esaki T et al.: Estrogen increases endothelial nitric oxide by a receptor-mediated system. Biochem Biophys Res Commun 1995;214:847-855
[8] Laursen JB, Rajagopalan S, Galis Z et al.: Role of superoxide in angiotensin II-induced but not catecholamine-II-induced hypertension. Circulation 1997;95:588-593 [9] Walsh BW, Schiff I, Rosner B, Greenberg L, Ravinkar V, Sacks FM: Effekts of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991;325:1196-1204
[10] Sack MN, Rader JR, Cannon RO: Estrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet 1994;343:269-270
[11] Subbiah MT, Kessel B, Agrawal M et al.: Antioxidant potential of specific estrogens on lipid peroxidation. J Clin Endocrinol Metab 1993;77:1095-1097
[12] Weiner CP, Lizasoain I, Baylis SA et al.: Induction of calcium-dependent nitric oxide Synthase by sex hormones. Proc Natl Acad Sci USA 1994;91:5212-5216
[13] Furchgott RF, Zawadski JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-76
[14] Silbernagl S, Despopoulos A: Taschenatlas der Physiologie. Georg Thieme Verlag Stuttgart, New York 6. Auflage 2000
[15] Schmidt RF, Thews G: Physiologie. Springer Verlag, 27. Auflage 1997
[16] Davies PF, Tripathi SC: Mechanical stress mechanisms and the cell. An endothelial paradigm. Circ Res 1993;72:239-245
[17] Gnasso A, Carallo C, Irace C et al.: Association between wall shear stress and flow-mediated vasodilation in healthy men. Atherosclerosis 2001;156:171-176
[18] Moens AL, Goovaerts I, Claeys MJ, Vrints C: Flow-mediated Vasodilation: A Diagnostic Instrument, or an Experimental Tool? Chest 2005;127:2254-2263
[19] Parsi RA, Parsi E: Kardiologie Angiologie. Urban und Fischer Verlag 1. Auflage 2001:371
[20] Halliwell B, Gutteridge JMC: Free Radicals in Biology and Medicine. Clarendon Press, Oxford 1989
[21] Gryglewski RJ, Palmer RM, Moncada S: Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986;320:454-456 [22] Ross R: The pathogenesis of atherosklerosis: a perspective for the 1990´s. Nature 1993;362:801-9
[23] Kugiyama K: Lysophosphatidylcholine inhibits surface receptor-mediated intracellular signals in endothelial cells by a pathway involving protein kinase C activation. Cir Res 1992;84:1420-5
[24] Ohgushi M: Proteinkinase C inhibitors prevent impairment of endothelium-dependent relaxation by oxidatively modified LDL. Arterioscler Thromb 1993;13:1525-32 [25] Liao JK: Regulation of G-protein alpha i2 subunit expression by oxidized low-density lipoprotein. J Clin Invest 1995;95:1457-63
[26] Tanner TF, Noll G, Boulanger CM, Lüscher TF: Oxidized low density lipoproteins inhibits relaxation of porcine coronary arteries. Role of scavenger receptor and endothelium-derived nitric oxide. Circulation 1991;83:2012-20
[27] Al-Qaisi M, Kharbanda R, Mittal T, Donald: Measurement of endothelial function and its clinical utility for cardiovascular risk. Vascular Health and Risk Managment 2008;4:647-652
[28] Deanfield JE, Halcox JP, Rabelink TJ: Endothelial function and dysfunction:
testing and clinical relevance. Circulation 2007;115:1285-1295
[29] Coretti MC, Anderson TJ, Benjamin EJ et al.: Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery:
A report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002;39:257-65
[30] Lieberman EH, Gerhard MD, Uehata A et al.: Flow-induced vasodilation of the human brachial artery is impaired in patients 40 years of age with coronary artery disease. Am J Cardiol 1996;78:1210-4
[31] Johannides R, Richard V, Haefeli WE et al.: Role of nitric oxide in the regulation of the mechanical properties of peripheral conduit arteries in humans. Hypertension 1997;30:1465-70
[32] Neunteufl T, Heher S, Katzenschlager R et al.: Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. Am J Cardiol 2000;86:207-10
[33] Gokce N, Keany JF Jr., Menziano JO et al.: Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function. Circulation 2002;105:1567-72
[34] Modena MG, Bonetti L, Coppi F, Bursi F, Rossi R: Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. J Am Coll Cardiol 2002;40:505-10
[35] Widlansky ME, Gokce N, Keany JF, Vita JA: The clinical Implications of Endothelial Dysfunction. J Am Coll Cardiol 2003;1149-60
[36] Gohlke H, Kübler W, Mathes P et al.: Empfehlungen für Patienten mit KHK, Gefäßerkrankung und Diabetes; Z Kardiol Steinkopff Verlag 90:148-149 2001
[37] Kris-Etherton PM, Hecker KD, Bonanome A et al.: Bioactive compounds in foods:
their role in the prevention of cardiovascular disease and cancer. Am J Med.
2002;113:71S-88S
[38] Nakachi K, Matsuyama S, Miyake S, Suganuma M, Imai K: Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. Biofactors 2000;13:49-54
[39] Stensvold I, Tverdal A, Solvoll K, Foss OP: Tea consumption. relationship to cholesterol, blood pressure, and coronary and total mortality. Prev. Med. 1992;21:546-553
[40] Knekt P, Järvinen R, Reunanen A, Maatela J: Flavonoid intake and coronary mortality in Finland. Br Med J 1996;312:478-481
[41] Yoshizawa T, Horiuchi T, Fujiki H: Antitumor promoting activity of (-)-epigallocatechin gallate, the main constituent of “tannin” in green tea. Phytother. Res. 1 1987;44-47
[42] Oppliger P: Der Grüne Tee. Lenzburg: pronto Kochbücher 2004
[43] Scholz E, Bertram B: Camellia sinensis (L.), O.Kuntze – Der Teestrauch.
Zeitschrift Phytoth 1995;17:235- 250
[44] Schröder R: Kaffee, Tee und Kardamon. Verlag Eugen Ulmer Stuttgart 1991
[45] Engelhardt U: Grüner und schwarzer Tee- Gemeinsamkeiten und Unterschiede.
Wissenschaftlicher Informationsdienst Tee. Ausgabe Frühjahr 1999 (www.teeverband.de)
[46] Balentine DA, Wiseman SA, Bouwens LC: The chemistry of tea flavonoids. Crit.
Rev. Food Sci. Nutr.1997;37:693-704
[47] McKay DL, Blumberg JB: The role of tea in human health. J Am Coll Nutr 2002;21:1-13
[48] Shahidi F: Nahrung 2000;3:158-163
[49] Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D: Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen elderly Study. Lancet 1993;342:1007-1011
[50] Geleijnse JM, Launer LJ, Hofman A, Pols HA, Witteman JC: Tea flavonoids may protect against atherosklerosis: The Rotterdam Study. Arch Intern Med 1999;159:2170-2174
[51] Ishikawa T, Suzukawa M, Ito T et al.: Effects of tea flavonoids supplementation on the susceptibility of low-density lipoprotein to oxidate modification. Am J Clin Nutr 1997;66:261-266
[52] Sano J, Inami S, Seimiya K et al.: Effects of green tea intake on the development of coronary artey disease. Circulation J 2004;68:665-670
[53] Hertog MG, Sweetnam PM, Fehily AM, Elwood PC, Kromhout D: Antioxidant flavonols and ischemic heart disease in a Welsh population of men: the Caerphilly Study. Am J Clin Nutr 1997;65:1489-1494
[54] Stangl V, Lorenz M, Stangl K: The role of tea flavonoids in cardiovascular health.
Mol. Nutr. Food Res. 2006;50:218-228
[55] Sanae F, Miyaichi Y, Kizu H, Hayashi H: Effects of catechins on vascular tone in rat thoracic aorta with endothelium. Life Sci 2002;71:2553-2562
[56] Shen JZ, Zheng XF, Wie EQ, Kwan CY: Green tea catechins evoke a phasic contraction in rat aorta via H²O²-mediated multiple signalling pathways. Clin Exp Pharmacol Physiol 2003;30:89-95
[57] Hertog M, Kromhout D, Aravanis C et al.: Flavonoid intake and long-term risk of coronary heart disease and cancer in the Seven Countries Study. Arch Intern Med 1995;155:381-386
[58] Lorenz M, Wesseler S, Follmann E et al.: A constituent of green tea, epigallocatechin-3-gallate, activates endothelial nitric oxide synthase by a
phosphatidylinositol-3-OH-kinase-, cAMP-dependent protein-kinase-, and Akt-dependent pathway and leads to endothelial-Akt-dependent vasorelaxation. J Biol Chem 2004 ;279:6190-6195
[59] Duffy SJ, Keany JF, Holbrook M: Short- and long-term black tea consumption reverses endothelial dysfunktion in patients with coronary artery disease. Circulation 2001;104:151-156
[60] Mukamal KJ, Maclure M, Muller JE, Sherwood JB, Mittleman MA: Tea consumption and mortality after acute myocardial infarction. Circulation 2002;105:2476-2481
[61] Rimm EB, Katan MB, Ascherio A, Stampfer MJ, Willett WC: Relation between intake of flavonoids and risk for coronary heart disease in male health professionals. Ann Intern. Med. 1996;125:384-389
[62] Woodward M, Tunstall-Pedoe H: Coffee and tea consumption in the Scottish Heart Health Study follow up: conflicting relations with coronary risk factors, coronary disease, and all cause mortality.
J Epidemiol Community Health. 1999;53:481-487.
[63] Sesso HD, Pfaffenbarger RS Jr, Oguma Y, Lee IM: Lack of association between tea and cardiovascular disease in college alumni.
Int J Epidemiol. 2003;32:527-533.
[64] Lorenz M, Urban J, Engelhardt U, Baumann G, Stangl K, Stangl V: Green and black tea are equally potent stimuli of NO production and vasodilation: new insights into tea ingredients involved. Basic Res Cardiol 2008;104:100-110
[65] Yoshida H, Ishikawa T, Hosoai H et al.: Inhibitory effect of tea flavonoids on the ability of cells to oxidize low density lipoprotein. Biochem Pharm 1999;58:1695-1703 [66] Menet MC, Sang S, Yang CS: Ho CT & Rosen RT Analysis of theaflavins and thearubigins from black tea extract by MALDI-TOF mass spectrometry. J Agric Food Chem 2004;52:2455-2461
[67] Lee KW, Lee HJ, Lee CY: Antioxidant activity of black tea vs. Green tea. J Nutr 2002;132:785
[68] Leung LK, Su Y, Chen R, Zhang Z, Huang Y, Chen ZY: Theaflavins in black tea and catechins in green tea are equally effective antioxidants. J Nutr. 2001;131:2248-2251
[69] Yoshino K, Hara Y, Sano M, Tomita I: Antioxidative effects of black tea theaflavins and thearubigins on lipid peroxidation of rat liver homogenates induced by tert-butyl hydroperoxide. Biol Pharm Bull 1994;17:146-149
[70] Graham HN: Green tea composition, consumption and polyphenol chemistry. Prev Med 1992;21:334-350
[71] Anter E, Chen K, Shapira OM et al.: p38 mitogen-activated protein kinase activates eNos in endothelial cells by an estrogen receptor alpha-dependent pathway in response to black tea polyphenols. Circ Res 2005;96:1072-1078
[72] Rice Evans CA, Miller NJ, Papaganga G: Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 1996;20:933-956 [73] Papadopoulo A, Frazier RA: Charactization of protein-polyphenol interactions.
Trends in Food Science & Technology 2004;15:186-190
[74] Siebert KJ, Troukhanova NV, Lynn PY: Nature of polyphenol-protein interactions.
Agric Food Chem 1996;44:80-85
[75] Arts MJ, Haenen GR, Voss HP, Bast A: Masking of antioxidant capacity by the interaction of flavonoids with proteins. Food Chem Toxicol 2001;39:787-791
[76] Luck G, Lioa H, Murray NJ et al.: Polyphenols, astringency and proline-rich proteins. Phytochemistry 1994;37:357-371
[77] Jobstl E, Howse JR, Fairclough JP, Williamson MP: Noncovalent cross-linking of casein by epigallocatechin gallate characterized by single molecule force microscopy. J Agric Food Chem 2006;54:4077-4081
[78] Krul C, Luiten-Schuite A, Tenfelde A et al.: Antimutagenic activity of green tea and black tea extracts studied in a dynamic in vitro gastrointestinal model. Mutat Res 2001;474:71-85
[79] Serafini M, Ghiselli A, Ferro-Luzzi A: In vivo antioxidant effect of green and black tea in man. Eur J Clin Nutr 1996;50:28-32
[80] Langley-Evans SC: Consumption of black tea elicits an increase in plasma antioxidant potential in humans. Int J Food Sci Nutr 2000;51:309-315
[81] Serafini M, Bugianesi R, Maiani G, Valtuena S, De Santis S, Crozier A: Plasma antioxidants from chocolate. Nature 2003;424:1013
[82] Leenen R, Roodenburg AJ, Tijburg LB, Wiseman SA: A single dose of tea with or without milk increases plasma antioxidant activity in humans. Eur J Clin Nutr 2000;54:87-92
[83] Reddy VC, Vidya Sagar GV Sreeramulu D, Venu L, Raghunath M: Addition of milk does not alter the antioxidant activity of black tea. Ann Nutr Metab 2005;49:189-195 [84] Schächinger V, Zeiher AM: Prognostic implications of endothelial dysfunction:
does it mean anything? Coronary artery disease 2001;12:435-443
Mein Lebenslauf wird aus datenschutzrechtlichen Gründen in der elektronischen Version meiner Arbeit nicht veröffentlicht.
Publikationen:
1. Jochmann N, Lorenz M, von Krosigk A, Martus P, Böhm V, Baumann G, Stangl K, Stangl V. The efficacy of black tea in ameliorating endothelial function is equivalent to that of green tea. British Journal of Nutrition. 2008 Apr; 99 (4):863-8. Epub 2007 Oct 5.
2. Lorenz M, Jochmann N, von Krosigk A, Martus P, Baumann G, Stangl K, Stangl V.
Addition of milk prevents vascular protective effects of tea. European Heart Journal.
2007 Jan; 28 (2):219-23. Epub 2007 Jan 9.